PMC8322976_01
(A) Initial bullous skin eruption involving the back of the patient after 24 hours from the second dose of the influenza vaccine; (B) Bullous lesions presented on the left foot of the patient after 24 hours from the second dose of the influenza vaccine.
fimmu-12-688364-g001.jpg
PMC8322976_04_fimmu-12-688364-g001.jpg
f1
One month later, the patient received the second dose of inactivated-tetravalent influenza vaccine, and after 24 hours from the injection, she presented an extensive bullous skin eruption involving the face, head, chest, shoulder, back, hands, and feet (  Figure 1  ).
PMC8322976_02
PMC8322976_03
PMC8322976_04
(A) Initial bullous skin eruption involving the back of the patient after 24 hours from the second dose of the influenza vaccine; (B) Bullous lesions presented on the left foot of the patient after 24 hours from the second dose of the influenza vaccine.
fimmu-12-688364-g001.jpg
PMC8322976_04_fimmu-12-688364-g001.jpg
f1
One month later, the patient received the second dose of inactivated-tetravalent influenza vaccine, and after 24 hours from the injection, she presented an extensive bullous skin eruption involving the face, head, chest, shoulder, back, hands, and feet (  Figure 1  ).
PMC8322976_05
PMC8322976_06
PMC8322976_07